Mohammed Al Amoudi’s and FastPartner’s bid for Allenex
Mannheimer Swartling is advising Mohammed Al Amoudi and FastPartner AB (publ) as well as their jointly owned bidding company on its mandatory bid for Allenex AB (publ).
Allenex, formerly LinkMed, is a life science company that develops, manufactures, markets and sells high quality products and services that facilitate safer transplantations with better results. The Allenex share is listed on NASDAQ OMX Stockholm.
Mannheimer Swartling’s team is led by Eva Hägg and Johan Ljungberg and includes Emil Boström, Johan Berg and Thérèze Buskas. Stefan Perván Lindeborg and Urszula Sieradzka from the firm’s Brussels office are advising on anti-trust matters.